Literature DB >> 8753876

Increased expression of IL-1beta converting enzyme in hippocampus after ischemia: selective localization in microglia.

R V Bhat1, R DiRocco, V R Marcy, D G Flood, Y Zhu, P Dobrzanski, R Siman, R Scott, P C Contreras, M Miller.   

Abstract

Although the interleukin-1beta converting enzyme (ICE)/CED-3 family of proteases has been implicated recently in neuronal cell death in vitro and in ovo, the role of specific genes belonging to this family in cell death in the nervous system remains unknown. To address this question, we examined the in vivo expression of one of these genes, Ice, after global forebrain ischemia in gerbils. Using RT-PCR and Western immunoblot techniques, we detected an increase in the mRNA and protein expression of ICE in hippocampus during a period of 4 d after ischemia. Chromatin condensation was observed in CA1 neurons within 2 d after ischemia. Internucleosomal DNA fragmentation and apoptotic bodies were observed between 3 and 4 d after ischemia, a period during which CA1 neuronal death is maximal. In nonischemic brains, ICE-like immunoreactivity was relatively low in CA1 pyramidal neurons but high in scattered hippocampal interneurons. After ischemia, ICE-like immunoreactivity was not altered in these neurons. ICE-like immunoreactivity, however, was observed in microglial cells in the regions adjacent to the CA1 layer as early as 2 d after ischemic insult. The increase in ICE-like immunoreactivity was robust at 4 d after ischemia, a period that correlates with the DNA fragmentation observed in hippocampal homogenates of ischemic brains. These results provide the first evidence for the localization and induction of ICE expression in vivo after ischemia and suggest an indirect role for ICE in ischemic damage through mediation of an inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8753876      PMCID: PMC6578997     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Why do neurons die when deprived of trophic factor?

Authors:  E M Johnson; J Y Chang; T Koike; D P Martin
Journal:  Neurobiol Aging       Date:  1989 Sep-Oct       Impact factor: 4.673

2.  Effects of cycloheximide on delayed neuronal death in rat hippocampus.

Authors:  K Goto; A Ishige; K Sekiguchi; S Iizuka; A Sugimoto; M Yuzurihara; M Aburada; E Hosoya; K Kogure
Journal:  Brain Res       Date:  1990-11-26       Impact factor: 3.252

3.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

4.  Brain glia release factors with opposing actions upon neuronal survival.

Authors:  D Giulian; K Vaca; M Corpuz
Journal:  J Neurosci       Date:  1993-01       Impact factor: 6.167

5.  Requirement for RNA and protein synthesis for induced regression of the tadpole tail in organ culture.

Authors:  J R Tata
Journal:  Dev Biol       Date:  1966-02       Impact factor: 3.582

6.  Cytotoxic Effect of Brain Macrophages on Developing Neurons.

Authors:  Clotilde Théry; Brigitte Chamak; Michel Mallat
Journal:  Eur J Neurosci       Date:  1991-10       Impact factor: 3.386

7.  ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis.

Authors:  H Duan; A M Chinnaiyan; P L Hudson; J P Wing; W W He; V M Dixit
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

8.  Inhibition of mature IL-1 beta production in murine macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1 beta converting enzyme.

Authors:  B E Miller; P A Krasney; D M Gauvin; K B Holbrook; D J Koonz; R V Abruzzese; R E Miller; K A Pagani; R E Dolle; M A Ator
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

9.  CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.

Authors:  T Fernandes-Alnemri; G Litwack; E S Alnemri
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

10.  Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family.

Authors:  T Fernandes-Alnemri; G Litwack; E S Alnemri
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

View more
  23 in total

1.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.

Authors:  J Yrjänheikki; R Keinänen; M Pellikka; T Hökfelt; J Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 2.  Annual review prize lecture cytokines - killers in the brain?

Authors:  N J Rothwell
Journal:  J Physiol       Date:  1999-01-01       Impact factor: 5.182

3.  Analysis of apoptosis during hair follicle regression (catagen)

Authors:  G Lindner; V A Botchkarev; N V Botchkareva; G Ling; C van der Veen; R Paus
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease.

Authors:  F Yang; X Sun; W Beech; B Teter; S Wu; J Sigel; H V Vinters; S A Frautschy; G M Cole
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis.

Authors:  Z Xu; A C Maroney; P Dobrzanski; N V Kukekov; L A Greene
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis.

Authors:  F Esch; K I Lin; A Hills; K Zaman; J M Baraban; S Chatterjee; L Rubin; D E Ash; R R Ratan
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

7.  Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

Authors:  Anna K Junk; Antonios Mammis; Sean I Savitz; Manjeet Singh; Steven Roth; Samit Malhotra; Pearl S Rosenbaum; Anthony Cerami; Michael Brines; Daniel M Rosenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-18       Impact factor: 11.205

8.  Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury.

Authors:  Juan Pablo de Rivero Vaccari; George Lotocki; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2009-04-29       Impact factor: 6.200

9.  Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.

Authors:  Seung-Woo Kim; Ji-Young Jeong; Hyun Ji Kim; Ji-Seon Seo; Pyung-Lim Han; Sung-Hwa Yoon; Ja-Kyeong Lee
Journal:  Neurotox Res       Date:  2009-07-28       Impact factor: 3.911

10.  Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo.

Authors:  P Kermer; N Klöcker; M Labes; M Bähr
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.